Fig. 3
From: Oncolytic virus immunotherapy: future prospects for oncology
a Inoculation of the oncoviral vaccine with antigen detection by dendritic cells and presentation to CD4+ and CD8+ lymphocytes with clonal expansion and antibody formation. b Induction of immune storm by cytotoxic T cell invasion, antibody mediated destruction, and complement formation with feedback autophagy and apoptosis. Orange: oncoviral vaccine. Blue: immune cells. Light green: antibodies. Teal: Complement